Long-lasting c-fos and NGF mRNA expressions and loss of perikaryal parvalbumin immunoreactivity in the development of epileptogenesis after ethacrynic acid-induced seizure

Brain Research

Volumn 834, Issue 1-2, 1999, Pages 89-102

  Suzukawa, Junko ^a   Omori, Kyoko ^a   Okugawa, Gaku ^a   Fujiseki, Yoshito ^a   Heizmann, C W ^b   Inagaki, Chiyoko ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Department of Pediatrics   (Switzerland)

Author keywords

c Fos; Ethacrynic acid; Generalized tonic clonic convulsion; Nerve growth factor; Parvalbumin; Seizure susceptibility

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; ANTICONVULSIVE AGENT; COMPLEMENTARY DNA; DIAZEPAM; DIZOCILPINE; ETACRYNIC ACID; KAINIC ACID; MESSENGER RNA; NERVE GROWTH FACTOR; PARVALBUMIN; PHENOBARBITAL; PROTEIN C FOS; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; EPILEPSY; EPILEPTOGENESIS; GENE EXPRESSION; GRAND MAL EPILEPSY; HIPPOCAMPUS; IMMEDIATE EARLY GENE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRIFORM CORTEX; QUANTITATIVE ASSAY; SEIZURE;

ANIMALS; CONVULSANTS; DISEASE SUSCEPTIBILITY; EPILEPSY; ETHACRYNIC ACID; EXCITATORY AMINO ACID ANTAGONISTS; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MALE; MICE; NERVE GROWTH FACTORS; NEURAL INHIBITION; PARVALBUMINS; PROTO-ONCOGENE PROTEINS C-FOS; RNA, MESSENGER; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0033542774     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01554-1     Document Type: Article

References (51)

1. Adams B., Sazgar M., Osehobo P., Van der Zee C.E.E.M., Diamond J., Fahnestock M., Racine R.J. Nerve growth factor accelerates seizure development, enhances mossy fiber sprouting, and attenuates seizure-induced decreases in neuronal density in kindling model of epilepsy. J. Neurosci. 17:1997;5288-5296.
2. Altar C.A., Burton L.E., Bennett G.L., Dugich-Djordjevic M. Recombinant human nerve growth factor is biologically active and labels novel high-affinity binding sites in rat brain. Proc. Natl. Acad. Sci. U.S.A. 88:1991;281-285.
3. Bing G., Wilson B., Hudson P., Jin L., Feng Z., Zhang W., Bing R., Hong J.S. A single dose of kainic acid elevates the levels of enkephalins and activator protein-1 transcription factors in the hippocampus for up to 1 year. Proc. Natl. Acad. Sci. U.S.A. 94:1997;9422-9427.
4. Blöchl A., Thoenen H. Characterization of nerve growth factor (NGF) release from hippocampal neurons: evidence for a constitutive and an unconventional sodium-dependent regulated pathway. Eur. J. Neurosci. 7:1995;1220-1228.
5. Bonnet U., Gastpar M., Bingmann D. Ethacrynic acid: effects on postsynaptic GABA responses and electric activity of CA3 neurones. NeuroReport. 7:1996;2983-2987.
6. Buckmaster P.S., Dudek F.E. Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrus of epileptic kainate-treated rats. J. Comp. Neurol. 385:1997;385-404.
7. Buhl E.H., Halasy K., Somogyi P. Diverse sources of hippocampal unitary inhibitory postsynaptic potentials and the number of synaptic release sites. Nature. 368:1994;823-828.
8. Cellerino A. Expression of messenger RNA coding for the nerve growth factor receptor trkA in the hippocampus of the adult rat. Neuroscience. 70:1996;613-616.
9. Cronin J., Dudek F.E. Chronic seizures and collateral sprouting of dentate mossy fibers after kainic acid treatment in rats. Brain Res. 474:1988;181-184.
10. D'Mello S.R., Heinrich G. Structural and functional identification of regulatory regions and cis elements surrounding the nerve growth factor gene promoter. Mol. Brain Res. 11:1991;255-264.
11. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
12. - in rat hippocampal neurons. Neurosci. Lett. 143:1992;135-138.
13. Hengerer B., Lindholm D., Heumann R., Rüther U., Wagner E.F., Thoenen H. Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc. Natl. Acad. Sci. U.S.A. 87:1990;3899-3903.
14. Hiroi N., Marek G.J., Brown J.R., Ye H., Saudou F., Vaidya V.A., Duman R.S., Greenberg M.E., Nestler E.J. Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. J. Neurosci. 18:1998;6952-6962.
15. Holmes G.L., Chronopoulos A., Stafstrom C.E., Mikati M.A., Thurber S.J., Hyde P.A., Thompson J.L. Effects of kindling on subsequent learning, memory, behavior, and seizure susceptibility. Dev. Brain Res. 73:1993;71-77.
16. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
17. Inoue M., Uriu T., Otani H., Hara M., Omori K., Inagaki C. Intracerebroventricular injection of ethacrynic acid induces status epilepticus. Eur. J. Pharmacol. 166:1989;101-106.
18. Inoue M., Hirose T., Inagaki C. Ethacrynic acid-induced glutamate release from mouse brain synaptosomes. Brain Res. 543:1991;160-162.
19. - concentrations in rat hippocampal neurons. Neurosci. Lett. 134:1991;75-78.
20. Kasof G.M., Mandelzys A., Maika S.D., Hammer R.E., Curran T., Morgan J.I. Kainic acid-induced neuronal death is associated with DNA damage and a unique immediate-early gene response in c-fos-lacZ transgenic rats. J. Neurosci. 15:1995;4238-4249.
21. Katsumaru H., Kosaka T., Heizmann C.W., Hama K. Immunocytochemical study of GABAergic neurons containing the calcium-binding protein parvalbumin in the rat hippocampus. Exp. Brain Res. 72:1988;347-362.
22. Kiessling M., Gass P. Immediate early gene expression in experimental epilepsy. Brain Pathol. 3:1993;381-393.
23. Knipper M., Leung L.S., Zhao D., Rylett R.J. Short-term modulation of glutamatergic synapses in adult rat hippocampus by NGF. NeuroReport. 5:1994;2433-2436.
24. Korsching S., Auburger G., Heumann R., Scott J., Thoenen H. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J. 4:1985;1389-1393.
25. 2+-binding protein parvalbumin in the rat hippocampus and dentate gyrus. Brain Res. 419:1987;119-130.
26. Lothman E.W., Bertram E.H. Epileptogenic effects of status epilepticus. Epilepsia. 34:1993;S59-S70.
27. Mandelzys A., Gruda M.A., Bravo R., Morgan J.I. Absence of a persistently elevated 37 kDa Fos-related antigen and AP-1-like DNA-binding activity in the brains of kainic acid-treated fosB null mice. J. Neurosci. 17:1997;5407-5415.
28. Marco P., Sola R.G., Pulido P., Alijarde M.T., Sánchez A., Ramón y Cajal S., DeFelipe J. Inhibitory neurons in the human epileptogenic temporal neocortex. An immunocytochemical study. Brain. 119:1996;1327-1347.
29. Morgan J.I., Curran T. Proto-oncogene transcription factors and epilepsy. Trends Pharmacol. Sci. 12:1991;343-349.
30. Nitsch C., Scotti A.L., Nitsch F.M. Distribution of parvalbumin-containing interneurons in the hippocampus of the gerbil - a qualitative and quantitative statistical analysis. J. Chem. Neuroanat. 9:1995;135-147.
31. Obenaus A., Esclapez M., Houser C.R. Loss of glutamate decarboxylase mRNA-containing neurons in the rat dentate gyrus following pilocarpine-induced seizures. J. Neurosci. 13:1993;4470-4485.
32. Pioro E.P., Cuello A.C. Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system: I. Forebrain. Neuroscience. 34:1990;57-87.
33. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
34. Represa A., Jorquera I., Le Gall La Salle G., Ben-Ari Y. Epilepsy induced collateral sprouting of hippocampal mossy fibers: does it induce the development of ectopic synapses with granule cell dendrites? Hippocampus. 3:1993;257-268.
35. Rhyner J.A., Durussel I., Cox J.A., Ilg E.C., Schäfer B.W., Heizmann C.W. Human recombinant alpha-parvalbumin and nine mutants with individually inactivated calcium- and magnesium-binding sites: biochemical and immunological properties. Biochim. Biophys. Acta. 1313:1996;179-186.
36. Rocamora N., Pascual M., Acsady L., de Lecea L., Freund T.F., Soriano E. Expression of NGF and NT-3 mRNAs in hippocampal interneurons innervated by the GABAergic septohippocampal pathway. J. Neurosci. 16:1996;3991-4004.
37. Scotti A.L., Kalt G., Bollag O., Nitsch C. Parvalbumin disappears from GABAergic CA1 neurons of the gerbil hippocampus with seizure onset while its presence persists in the perforant path. Brain Res. 760:1997;109-117.
38. Scotti A.L., Bollag O., Kalt G., Nitsch C. Loss of perikaryal parvalbumin immunoreactivity from surviving GABAergic neurons in the CA1 field of epileptic gerbils. Hippocampus. 7:1997;524-535.
39. Shelton D.L., Reichardt L.F. Studies on the expression of the β-nerve growth factor (NGF) gene in the central nervous system: level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons. Proc. Natl. Acad. Sci. U.S.A. 83:1986;2714-2718.
40. - pump in the brain. J. Biol. Chem. 264:1989;17416-17421.
41. Sloviter R. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science. 235:1987;73-76.
42. Sloviter R. Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: the "dormant basket cell" hypothesis and its possible relevance to temporal lobe epilepsy. Hippocampus. 1:1991;41-66.
43. Smeyne R.J., Vendrell M., Hayward M., Baker S.J., Miao G.G., Schilling K., Robertson L.M., Curran T., Morgan J.I. Continuous c-fos expression precedes programmed cell death in vivo. Nature. 363:1993;166-169.
44. Soltesz I., Smetters D.K., Mody I. Tonic inhibition originates from synapses close to the soma. Neuron. 14:1995;1273-1283.
45. Sperk G., Marksteiner J., Gruber B., Bellmann R., Mahata M., Ortler M. Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat. Neuroscience. 50:1992;831-846.
46. Sutula T., Xiao-Xian H., Cavazos J., Scott G. Synaptic reorganization in the hippocampus induced by abnormal functional activity. Science. 239:1988;1147-1150.
47. van Beveren C., van Straaten F., Curran T., Müller R., Verma I.M. Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell. 32:1983;1241-1255.
48. van der Zee C.E.E.M., Rashid K., Le K., Moore K., Stanisz J., Diamond J., Racine R.J., Fahnestock M. Intraventricular administration of antibodies to nerve growth factor retards kindling and blocks mossy fiber sprouting in adult rats. J. Neurosci. 15:1995;5316-5323.
49. Watanabe Y., Johnson R.S., Butler L.S., Binder D.K., Spiegelman B.M., Papaioannou V.E., McNamara J.O. Null mutation of c-fos impairs structural and functional plasticities in the kindling model of epilepsy. J. Neurosci. 16:1996;3827-3836.
50. Whittemore S.R., Ebendal T., Lärckfors L., Olson L., Seiger A., Strömberg I., Persson H. Developmental and regional expression of β-nerve growth factor messenger RNA and protein in the rat central nervous system. Proc. Natl. Acad. Sci. U.S.A. 83:1986;817-821.
51. Whittemore S.R., Friedman P.L., Larhammar D., Persson H., Gonzalez-Carvajal M., Holets V.R. Rat β-nerve growth factor sequence and site of synthesis in the adult hippocampus. J. Neurosci. Res. 20:1988;403-410.